Gazyva 1,000 MG/40 ML vial 40ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQT6D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,978
Award facts
- Contract value 100% obligated
- $30,977.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $30,977.82 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of GAZYVA (obinutuzumab) 1,000 mg/40 mL vials. The contract is a firm fixed-price delivery order with an ultimate completion date of January 28, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made on a fully competitive, non-set-aside basis and represents a task order under AmerisourceBergen's substantially larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal agencies with comprehensive medical supply solutions.
The supply of GAZYVA, a monoclonal antibody used in oncology and hematology treatment, supports the DLA's mission to provide critical pharmaceuticals to military healthcare systems and treatment facilities worldwide. AmerisourceBergen's extensive pharmaceutical supply portfolio and demonstrated capability to fulfill federal procurement requirements through open competition made it well-positioned for this delivery order. The DLA's Medical Supply Chain relies on such delivery orders under the prime vendor contract to ensure timely availability of specialized medications across the military healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26FQT6D?
SPE2DR26FQT6D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FQT6D worth?
The government has obligated $30,978 on SPE2DR26FQT6D.
Is contract SPE2DR26FQT6D an order under another contract?
Yes. SPE2DR26FQT6D is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQT6D competed?
The extent of competition for SPE2DR26FQT6D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award